Flawed study skews pediatric depression treatment, raising questions about scientific integrity
A 20-year-old Iranian study with only 40 participants disproportionately influenced a meta-analysis promoting Prozac for childhood depression.
Flawed clinical evidence led to biased guidelines, prioritizing Prozac over other treatments despite limited conclusive data.
The incident highlights risks of relying on single studies and the need for rigorous, transparent scientific analysis.
Psychotropic medications, as health technologies, require careful evaluation of risks and benefits, particularly for children.
Science must remain self-correcting, reanalyzing data to avoid misleading conclusions and protect public health.
Read Full Article: https://www.naturalnews.com/2026-10-21-flawed-study-skews-pediatric-depression-treatment-raising-questions.html
